002940 Stock Overview
A pharmaceutical company, engages in manufacturing APIs and pharmaceutical preparations for oral cephalosporins, cardiovascular, and kidney diseases. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
Zhejiang AngLiKang Pharmaceutical CO.,LTD. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥14.14 |
| 52 Week High | CN¥22.59 |
| 52 Week Low | CN¥11.82 |
| Beta | 0.076 |
| 11 Month Change | 3.36% |
| 3 Month Change | 13.85% |
| 1 Year Change | -34.99% |
| 33 Year Change | -12.20% |
| 5 Year Change | 5.61% |
| Change since IPO | -10.51% |
Recent News & Updates
Recent updates
Shareholder Returns
| 002940 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -2.5% | -5.2% | -4.1% |
| 1Y | -35.0% | -6.7% | 3.8% |
Return vs Industry: 002940 underperformed the CN Pharmaceuticals industry which returned -6.7% over the past year.
Return vs Market: 002940 underperformed the CN Market which returned 3.8% over the past year.
Price Volatility
| 002940 volatility | |
|---|---|
| 002940 Average Weekly Movement | 5.9% |
| Pharmaceuticals Industry Average Movement | 7.2% |
| Market Average Movement | 8.2% |
| 10% most volatile stocks in CN Market | 12.6% |
| 10% least volatile stocks in CN Market | 5.6% |
Stable Share Price: 002940 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 002940's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | 1,290 | Guo Zheng | www.alkpharm.com |
Zhejiang AngLiKang Pharmaceutical CO.,LTD., a pharmaceutical company, engages in manufacturing APIs and pharmaceutical preparations for oral cephalosporins, cardiovascular, and kidney diseases. The company also offers products in the areas of anti-infection, antihypertensive, digestive system, central nervous diseases, and respiratory preparations. The company was founded in 2001 and is based in Shengzhou, China.
Zhejiang AngLiKang Pharmaceutical CO.,LTD. Fundamentals Summary
| 002940 fundamental statistics | |
|---|---|
| Market cap | CN¥2.80b |
| Earnings (TTM) | CN¥78.51m |
| Revenue (TTM) | CN¥1.56b |
36.0x
P/E Ratio1.8x
P/S RatioIs 002940 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 002940 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.56b |
| Cost of Revenue | CN¥938.51m |
| Gross Profit | CN¥621.93m |
| Other Expenses | CN¥543.42m |
| Earnings | CN¥78.51m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.39 |
| Gross Margin | 39.86% |
| Net Profit Margin | 5.03% |
| Debt/Equity Ratio | 31.6% |
How did 002940 perform over the long term?
See historical performance and comparison